MIM
IMGN

MetLife Investment Management’s Immunogen Inc IMGN Stock Holding History

MetLife Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,461
Closed -$3.72M – 2846
2023
Q4 		$3.72M Sell
125,461
-2,433
-2% -$48.5K 0.03% 649
2023
Q3 		$2.03M Hold
127,894
– – 0.02% 897
2023
Q2 		$2.41M Buy
127,894
+17,450
+16% +$206K 0.02% 857
2023
Q1 		$424K Hold
110,444
– – ﹤0.01% 1745
2022
Q4 		$548K Hold
110,444
– – ﹤0.01% 1585
2022
Q3 		$528K Buy
110,444
+9,667
+10% +$51K ﹤0.01% 1597
2022
Q2 		$453K Sell
100,777
-7,699
-7% -$33.4K ﹤0.01% 1731
2022
Q1 		$516K Buy
108,476
+38,679
+55% +$214K ﹤0.01% 1752
2021
Q4 		$518K Buy
69,797
+10,556
+18% +$65.6K ﹤0.01% 1488
2021
Q3 		$336K Sell
59,241
-14,457
-20% -$83.5K ﹤0.01% 1762
2021
Q2 		$486K Hold
73,698
– – ﹤0.01% 1591
2021
Q1 		$597K Buy
73,698
+14,366
+24% +$117K 0.01% 1424
2020
Q4 		$383K Buy
59,332
+3,331
+6% +$19.4K ﹤0.01% 1611
2020
Q3 		$202K Sell
56,001
-21,499
-28% -$86.8K ﹤0.01% 1862
2020
Q2 		$357K Hold
77,500
– – ﹤0.01% 1563
2020
Q1 		$264K Buy
77,500
+17,754
+30% +$77.6K ﹤0.01% 1545
2019
Q4 		$305K Hold
59,746
– – ﹤0.01% 1737
2019
Q3 		$145K Hold
59,746
– – ﹤0.01% 2127
2019
Q2 		$130K Hold
59,746
– – ﹤0.01% 2261
2019
Q1 		$162K Hold
59,746
– – ﹤0.01% 2089
2018
Q4 		$287K Hold
59,746
– – ﹤0.01% 1708
2018
Q3 		$566K Hold
59,746
– – 0.01% 1457
2018
Q2 		$581K Buy
59,746
+13,727
+30% +$145K 0.01% 1321
2018
Q1 		$484K Hold
46,019
– – 0.01% 1387
2017
Q4 		$295K Buy
+46,019
New +$284K ﹤0.01% 1720

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MetLife Investment Management's IMGN Position: Q1 2024 in Review

MetLife Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 125,461 shares — an estimated $3.72M sold.

MetLife Investment Management first reported a position in IMGN in Q4 2017 and held it in 25 quarters. The position peaked at $3.72M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • MetLife Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • MetLife Investment Management sold 125,461 Immunogen Inc shares in Q1 2024, an estimated $3.72M.
  • MetLife Investment Management first reported a position in Immunogen Inc in Q4 2017 and held it in 25 quarters.
  • MetLife Investment Management's Immunogen Inc position peaked at $3.72M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.